If you purchased Robitussin Non-Drowsy products containing dextromethorphan (DXM) between February 16, 2016, and January 21, 2025, you may be eligible for a cash payout from this class action settlement!
Who’s Eligible?
Anyone in the U.S. who bought a covered Robitussin Non-Drowsy product for personal or household use (not for resale) during the Class Period.
Potential Payout
- Estimated between $1.50 and $4.75 per claim
- Final amount depends on the number of claims submitted
Proof of Purchase?
✅ Not required!
Claim Deadline
May 12, 2025
If you qualify, submit your claim before the deadline to receive your share of the settlement!
